HRT Financial’s Kronos Bio KRON Stock Holding History

HRT Financial’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,596	Closed	-$11K	–	3137
2025 Q1	$11K	Buy	+13,596	New	+$13.1K	﹤0.01%	2347
2022 Q4	–	Sell	-81,588	Closed	-$273K	–	2830
2022 Q3	$273K	Sell	81,588 -90,487	-53%	-$408K	﹤0.01%	2055
2022 Q2	$626K	Buy	172,075 +74,387	+76%	+$337K	0.01%	1326
2022 Q1	$706K	Buy	+97,688	New	+$833K	0.01%	1379

HRT Financial's KRON Position: Q2 2025 in Review

HRT Financial sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 13,596 shares — an estimated $11K sold.

HRT Financial first reported a position in KRON in Q1 2022 and held it in 4 quarters. The position peaked at $706K in Q1 2022. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

HRT Financial reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 13,596 Kronos Bio shares in Q2 2025, an estimated $11K.
HRT Financial first reported a position in Kronos Bio in Q1 2022 and held it in 4 quarters.
HRT Financial's Kronos Bio position peaked at $706K in Q1 2022.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.